Kevin Sprott

Kevin Sprott is an accomplished pharmaceutical executive currently serving as Chief Operating Officer at Peptone since August 2024. Sprott has extensive experience in drug discovery and development, holding previous roles such as COO and Senior Vice President at Stablix, Inc., and Senior Director at Syros Pharmaceuticals and Verastem, Inc. In addition to consulting positions, Sprott has contributed to innovative cancer research initiatives at the Hope Funds for Cancer Research. With a robust intellectual property portfolio of 25 patents related to chemistry and small molecule drug discoveries, Sprott combines a strong scientific background with practical leadership experience, holding a Ph.D. in Chemistry from Harvard University and a Bachelor of Science in Biology from Wake Forest University.